Accessory cells precondition naïve T cells and regulatory T cells for cytokine-mediated proliferation

por Sato, Noriko, Bamford, Richard N., Bryant, Bonita R., Tagaya, Yutaka, Waldmann, Thomas A.
Publicado 2023

Clinical trial of a humanized anti‐IL‐2/IL‐15 receptor β chain in HAM/TSP

por Enose‐Akahata, Yoshimi, Oh, Unsong, Ohayon, Joan, Billioux, Bridgette Jeanne, Massoud, Raya, Bryant, Bonita R., Vellucci, Ashley, Ngouth, Nyater, Cortese, Irene, Waldmann, Thomas A., Jacobson, Steven
Publicado 2019

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

por Daenthanasanmak, Anusara, Lin, Yuquan, Zhang, Meili, Bryant, Bonita R., Petrus, Michael N., Bamford, Richard N., Thomas, Craig J., Miljkovic, Milos D., Conlon, Kevin C., Waldmann, Thomas A.
Publicado 2020

Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

por Dubois, Sigrid P, Miljkovic, Milos D, Fleisher, Thomas A, Pittaluga, Stefania, Hsu-Albert, Jennifer, Bryant, Bonita R, Petrus, Michael N, Perera, Liyanage P, Müller, Jürgen R, Shih, Joanna H, Waldmann, Thomas A, Conlon, Kevin C
Publicado 2021

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma

por Daenthanasanmak, Anusara, Bamford, Richard N., Yoshioka, Makoto, Yang, Shyh-Ming, Homan, Philip, Karim, Baktiar, Bryant, Bonita R., Petrus, Michael N., Thomas, Craig J., Green, Patrick L., Miljkovic, Milos D., Conlon, Kevin C., Waldmann, Thomas A.
Publicado 2022